- Home
- WHF vs LNSR Comparison
WHF vs LNSR Comparison
Compare WHF & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHF
- LNSR
- Stock Information
- Founded
- WHF 2011
- LNSR 2004
- Country
- WHF United States
- LNSR United States
- Employees
- WHF N/A
- LNSR N/A
- Industry
- WHF Finance Companies
- LNSR Medical Electronics
- Sector
- WHF Finance
- LNSR Health Care
- Exchange
- WHF Nasdaq
- LNSR Nasdaq
- Market Cap
- WHF 162.2M
- LNSR 142.0M
- IPO Year
- WHF 2012
- LNSR N/A
- Fundamental
- Price
- WHF $7.02
- LNSR $10.23
- Analyst Decision
- WHF Hold
- LNSR Hold
- Analyst Count
- WHF 3
- LNSR 1
- Target Price
- WHF $9.17
- LNSR $15.00
- AVG Volume (30 Days)
- WHF 149.6K
- LNSR 73.5K
- Earning Date
- WHF 11-10-2025
- LNSR 11-06-2025
- Dividend Yield
- WHF 25.36%
- LNSR N/A
- EPS Growth
- WHF N/A
- LNSR N/A
- EPS
- WHF 0.42
- LNSR N/A
- Revenue
- WHF $76,339,000.00
- LNSR $59,141,000.00
- Revenue This Year
- WHF N/A
- LNSR $30.80
- Revenue Next Year
- WHF N/A
- LNSR $33.09
- P/E Ratio
- WHF $16.60
- LNSR N/A
- Revenue Growth
- WHF N/A
- LNSR 21.02
- 52 Week Low
- WHF $6.39
- LNSR $7.00
- 52 Week High
- WHF $11.31
- LNSR $17.31
- Technical
- Relative Strength Index (RSI)
- WHF 47.32
- LNSR 29.40
- Support Level
- WHF $6.39
- LNSR $9.84
- Resistance Level
- WHF $7.40
- LNSR $12.60
- Average True Range (ATR)
- WHF 0.23
- LNSR 0.49
- MACD
- WHF -0.00
- LNSR -0.19
- Stochastic Oscillator
- WHF 61.88
- LNSR 9.82
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.